Titre : Lectines liant le mannose

Lectines liant le mannose : Questions médicales fréquentes

Termes MeSH sélectionnés :

Early Detection of Cancer
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Lectines liant le mannose : Questions médicales les plus fréquentes", "headline": "Lectines liant le mannose : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Lectines liant le mannose : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-13", "dateModified": "2025-03-10", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Lectines liant le mannose" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Lectines", "url": "https://questionsmedicales.fr/mesh/D037102", "about": { "@type": "MedicalCondition", "name": "Lectines", "code": { "@type": "MedicalCode", "code": "D037102", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.503" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Lectine liant le mannose", "alternateName": "Mannose-Binding Lectin", "url": "https://questionsmedicales.fr/mesh/D037601", "about": { "@type": "MedicalCondition", "name": "Lectine liant le mannose", "code": { "@type": "MedicalCode", "code": "D037601", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.503.311.500" } } } ], "about": { "@type": "MedicalCondition", "name": "Lectines liant le mannose", "alternateName": "Mannose-Binding Lectins", "code": { "@type": "MedicalCode", "code": "D037241", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Jatinder Singh", "url": "https://questionsmedicales.fr/author/Jatinder%20Singh", "affiliation": { "@type": "Organization", "name": "Department of Molecular Biology and Biochemistry, Guru Nanak Dev University, Amritsar, India." } }, { "@type": "Person", "name": "Manpreet Kaur", "url": "https://questionsmedicales.fr/author/Manpreet%20Kaur", "affiliation": { "@type": "Organization", "name": "Department of Human Genetics, Guru Nanak Dev University, Amritsar, India." } }, { "@type": "Person", "name": "Namarta Kalia", "url": "https://questionsmedicales.fr/author/Namarta%20Kalia", "affiliation": { "@type": "Organization", "name": "Department of Molecular Biology and Biochemistry, Guru Nanak Dev University, Amritsar, India." } }, { "@type": "Person", "name": "Kárita Cláudia Freitas Lidani", "url": "https://questionsmedicales.fr/author/K%C3%A1rita%20Cl%C3%A1udia%20Freitas%20Lidani", "affiliation": { "@type": "Organization", "name": "Laboratory of Molecular Immunopathology, Clinical Hospital, Federal University of Paraná, Curitiba, Brazil." } }, { "@type": "Person", "name": "Fabiana Antunes Andrade", "url": "https://questionsmedicales.fr/author/Fabiana%20Antunes%20Andrade", "affiliation": { "@type": "Organization", "name": "Laboratory of Molecular Immunopathology, Clinical Hospital, Federal University of Paraná, Curitiba, Brazil." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Fabrication of Antibody Conjugated Super Magnetic Oxide Nanoparticles for Early Detection of Prostate Cancer.", "datePublished": "2023-06-01", "url": "https://questionsmedicales.fr/article/37378940", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.31557/APJCP.2023.24.6.2089" } }, { "@type": "ScholarlyArticle", "name": "Epigenomic Blood-Based Early Detection of Pancreatic Cancer Employing Cell-Free DNA.", "datePublished": "2023-03-24", "url": "https://questionsmedicales.fr/article/36967102", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.cgh.2023.03.016" } }, { "@type": "ScholarlyArticle", "name": "Pancreatic Cancer: Changing Epidemiology and New Approaches to Risk Assessment, Early Detection, and Prevention.", "datePublished": "2023-02-18", "url": "https://questionsmedicales.fr/article/36804602", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1053/j.gastro.2023.02.012" } }, { "@type": "ScholarlyArticle", "name": "Performance of a targeted methylation-based multi-cancer early detection test by race and ethnicity.", "datePublished": "2022-12-07", "url": "https://questionsmedicales.fr/article/36495927", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ypmed.2022.107384" } }, { "@type": "ScholarlyArticle", "name": "A simplified multiplex methylated DNA testing for early detection of colorectal cancer in stool DNA.", "datePublished": "2022-10-06", "url": "https://questionsmedicales.fr/article/36203138", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12876-022-02512-6" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Acides aminés, peptides et protéines", "item": "https://questionsmedicales.fr/mesh/D000602" }, { "@type": "ListItem", "position": 3, "name": "Protéines", "item": "https://questionsmedicales.fr/mesh/D011506" }, { "@type": "ListItem", "position": 4, "name": "Lectines", "item": "https://questionsmedicales.fr/mesh/D037102" }, { "@type": "ListItem", "position": 5, "name": "Lectines liant le mannose", "item": "https://questionsmedicales.fr/mesh/D037241" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Lectines liant le mannose - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Lectines liant le mannose", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-15", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Lectines liant le mannose", "description": "Comment diagnostiquer une déficience en lectines liant le mannose ?\nQuels tests sont utilisés pour évaluer les lectines ?\nLes niveaux de lectines peuvent-ils varier ?\nQuels symptômes peuvent indiquer un problème avec les lectines ?\nPeut-on mesurer les lectines dans d'autres fluides ?", "url": "https://questionsmedicales.fr/mesh/D037241?mesh_terms=Early+Detection+of+Cancer&page=8#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Lectines liant le mannose", "description": "Quels symptômes sont associés à une déficience en lectines ?\nLes symptômes varient-ils selon l'âge ?\nY a-t-il des signes cutanés associés ?\nLes symptômes sont-ils toujours visibles ?\nLes symptômes peuvent-ils s'aggraver avec le temps ?", "url": "https://questionsmedicales.fr/mesh/D037241?mesh_terms=Early+Detection+of+Cancer&page=8#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Lectines liant le mannose", "description": "Comment prévenir les infections chez les patients déficients ?\nL'alimentation joue-t-elle un rôle dans la prévention ?\nLes exercices physiques sont-ils bénéfiques ?\nY a-t-il des mesures spécifiques à prendre ?\nLes consultations médicales régulières sont-elles importantes ?", "url": "https://questionsmedicales.fr/mesh/D037241?mesh_terms=Early+Detection+of+Cancer&page=8#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Lectines liant le mannose", "description": "Quels traitements sont disponibles pour les déficiences en lectines ?\nLes suppléments peuvent-ils aider ?\nLa vaccination est-elle recommandée ?\nY a-t-il des traitements expérimentaux ?\nLes traitements sont-ils personnalisés ?", "url": "https://questionsmedicales.fr/mesh/D037241?mesh_terms=Early+Detection+of+Cancer&page=8#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Lectines liant le mannose", "description": "Quelles complications peuvent survenir avec une déficience en lectines ?\nLes infections peuvent-elles être mortelles ?\nY a-t-il un risque accru de cancer ?\nLes complications sont-elles réversibles ?\nComment surveiller les complications ?", "url": "https://questionsmedicales.fr/mesh/D037241?mesh_terms=Early+Detection+of+Cancer&page=8#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Lectines liant le mannose", "description": "Quels sont les facteurs de risque pour les déficiences en lectines ?\nL'âge influence-t-il le risque ?\nLes maladies auto-immunes augmentent-elles le risque ?\nLe mode de vie affecte-t-il le risque ?\nLes infections chroniques sont-elles un facteur de risque ?", "url": "https://questionsmedicales.fr/mesh/D037241?mesh_terms=Early+Detection+of+Cancer&page=8#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une déficience en lectines liant le mannose ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins peuvent mesurer les niveaux de lectines et évaluer la fonction immunitaire." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer les lectines ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests d'immunoessai et les dosages enzymatiques sont couramment utilisés." } }, { "@type": "Question", "name": "Les niveaux de lectines peuvent-ils varier ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les niveaux de lectines peuvent fluctuer en fonction de l'état de santé et des infections." } }, { "@type": "Question", "name": "Quels symptômes peuvent indiquer un problème avec les lectines ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des infections récurrentes ou des maladies auto-immunes peuvent signaler un dysfonctionnement." } }, { "@type": "Question", "name": "Peut-on mesurer les lectines dans d'autres fluides ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les lectines peuvent également être mesurées dans les fluides corporels comme la salive." } }, { "@type": "Question", "name": "Quels symptômes sont associés à une déficience en lectines ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des infections fréquentes, des allergies et des maladies auto-immunes." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon l'âge ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent se manifester différemment chez les enfants et les adultes." } }, { "@type": "Question", "name": "Y a-t-il des signes cutanés associés ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des éruptions cutanées peuvent survenir en raison de réactions immunitaires anormales." } }, { "@type": "Question", "name": "Les symptômes sont-ils toujours visibles ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Non, certains patients peuvent être asymptomatiques malgré une déficience en lectines." } }, { "@type": "Question", "name": "Les symptômes peuvent-ils s'aggraver avec le temps ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, sans traitement, les symptômes peuvent devenir plus graves et fréquents." } }, { "@type": "Question", "name": "Comment prévenir les infections chez les patients déficients ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Une bonne hygiène, des vaccinations et un suivi médical régulier sont essentiels." } }, { "@type": "Question", "name": "L'alimentation joue-t-elle un rôle dans la prévention ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation équilibrée peut renforcer le système immunitaire et la santé globale." } }, { "@type": "Question", "name": "Les exercices physiques sont-ils bénéfiques ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice régulier peut améliorer la santé immunitaire et réduire le stress." } }, { "@type": "Question", "name": "Y a-t-il des mesures spécifiques à prendre ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Éviter les foules et se laver les mains fréquemment sont des mesures préventives clés." } }, { "@type": "Question", "name": "Les consultations médicales régulières sont-elles importantes ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des consultations régulières permettent de surveiller la santé et d'ajuster les traitements." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour les déficiences en lectines ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des thérapies immunomodulatrices et des antibiotiques préventifs." } }, { "@type": "Question", "name": "Les suppléments peuvent-ils aider ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Des suppléments nutritionnels peuvent soutenir le système immunitaire, mais pas spécifiquement les lectines." } }, { "@type": "Question", "name": "La vaccination est-elle recommandée ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les vaccinations peuvent aider à prévenir les infections chez les patients à risque." } }, { "@type": "Question", "name": "Y a-t-il des traitements expérimentaux ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Des recherches sont en cours sur des thérapies géniques et des traitements ciblés." } }, { "@type": "Question", "name": "Les traitements sont-ils personnalisés ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les traitements peuvent être adaptés en fonction des besoins individuels du patient." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec une déficience en lectines ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des infections graves, des maladies auto-immunes et des allergies." } }, { "@type": "Question", "name": "Les infections peuvent-elles être mortelles ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines infections peuvent être fatales si elles ne sont pas traitées rapidement." } }, { "@type": "Question", "name": "Y a-t-il un risque accru de cancer ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Certaines études suggèrent un risque accru de cancer chez les patients immunodéprimés." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être gérées, mais d'autres peuvent causer des dommages permanents." } }, { "@type": "Question", "name": "Comment surveiller les complications ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Des examens réguliers et des tests de laboratoire aident à surveiller les complications potentielles." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour les déficiences en lectines ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les antécédents familiaux, les infections fréquentes et certaines maladies génétiques sont des facteurs de risque." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les jeunes enfants et les personnes âgées sont plus susceptibles de présenter des déficiences." } }, { "@type": "Question", "name": "Les maladies auto-immunes augmentent-elles le risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes atteintes de maladies auto-immunes peuvent avoir un risque accru de déficiences." } }, { "@type": "Question", "name": "Le mode de vie affecte-t-il le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Un mode de vie malsain, comme le tabagisme, peut augmenter le risque de déficiences immunitaires." } }, { "@type": "Question", "name": "Les infections chroniques sont-elles un facteur de risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les infections chroniques peuvent affaiblir le système immunitaire et augmenter le risque." } } ] } ] }

Sources (10000 au total)

Fabrication of Antibody Conjugated Super Magnetic Oxide Nanoparticles for Early Detection of Prostate Cancer.

Prostate cancer is one of the most widespread cancers in the world. Early diagnosis is the most important factor in treatment efficiency. Furthermore, new methods for early diagnosis and treatment pla... Anti- PSCA antibodies were purified and conjugated to super magnetic oxide nanoparticles (SPION). Then, iron staining on prostate adenocarcinoma tissues was performed. At the same time, immunohistoche... In adenocarcinoma tissues with iron staining, many blue spots are seen compared to benign tissues, and the number of these spots increases with increasing tumor grade.... These findings indicate the characteristic of iron staining as a conjugate antibody to iron can be an appropriate approach to specific staining of tumor markers in cancer tissues and can be used to di...

Epigenomic Blood-Based Early Detection of Pancreatic Cancer Employing Cell-Free DNA.

Early detection of pancreatic cancer (PaC) can drastically improve survival rates. Approximately 25% of subjects with PaC have type 2 diabetes diagnosed within 3 years prior to the PaC diagnosis, sugg... Blood was collected from 132 subjects with PaC and 528 noncancer subjects to generate epigenomic and genomic feature sets yielding a predictive PaC signal algorithm. The algorithm was validated in a b... 5hmC differential profiling and additional genomic features enabled the development of a machine learning algorithm capable of distinguishing subjects with PaC from noncancer subjects with high specif... The PaC detection test showed robust early-stage detection of PaC signal in the studied cohorts with varying type 2 diabetes status. This assay merits further clinical validation for the early detecti...

A simplified multiplex methylated DNA testing for early detection of colorectal cancer in stool DNA.

ColoDefense1.0 assay has demonstrated its excellent sensitivity and specificity for early detection of colorectal cancer (CRC) by detecting the methylation levels of SDC2 and SEPT9, while exhibited li... A total 529 stool specimens were collected, and 244 CRC patients, 34 patients with advanced adenomas (AA), 64 with small polyps (SP) and 187 control subjects were divided in training and validation co... The stool DNA quantity stored in preservative buffer at 37 °C up to 7 days exhibited no significant decrease. In the training cohort, when the number of replicates reduced from 3 to 1, the overall per... The simplified ColoDefense test maintained the overall performance while reduced the number of PCR reactions to 1/3, and provided an effective and convenient tool to detect early CRC and precancerous ...

Usefulness of cardiac magnetic resonance for early detection of cancer therapeutics-related cardiac dysfunction in breast cancer patients.

Prognosis of breast cancer patients has been improved along with the progress in cancer therapies. However, cancer therapeutics-related cardiac dysfunction (CTRCD) has been an emerging issue. For earl... We prospectively enrolled 83 consecutive chemotherapy-naïve female patients with breast cancer (mean age, 56 ± 13 yrs.) between 2017 and 2020. CTRCD was defined based on echocardiography as left ventr... A total of 164 CMRs were performed in 83 patients. LVEF and GLS were significantly decreased after chemotherapy (LVEF, from 71.2 ± 4.4 to 67.6 ± 5.8%; GLS, from -27.9 ± 3.9 to -24.7 ± 3.5%, respective... These results indicate that CMR is useful to detect chemotherapy-related myocardial damage and predict for the development of CTRCD in breast cancer patients....

Air Pollution and Lung Cancer: A Review by International Association for the Study of Lung Cancer Early Detection and Screening Committee.

The second leading cause of lung cancer is air pollution. Air pollution and smoking are synergistic. Air pollution can worsen lung cancer survival.... The Early Detection and Screening Committee of the International Association for the Study of Lung Cancer formed a working group to better understand issues in air pollution and lung cancer. These inc... The number of estimated attributable lung cancer deaths has increased by nearly 30% since 2007 as smoking has decreased and air pollution has increased. In 2013, the International Agency for Research ... Worldwide air pollution levels vary widely, and the exposed populations also differ. Advocacy to lower sources of exposure is important. Health care can lower its environmental footprint, becoming mor...

A Systematic Review of Diagnostic Performance of Circulating MicroRNAs in Colorectal Cancer Detection with a Focus on Early-Onset Colorectal Cancer.

The rising incidence and mortality of early-onset colorectal cancer (EOCRC) emphasize the urgent need for effective non-invasive screening. Circulating microRNAs (miRNAs) have emerged as promising bio...